Bill Baruch’s Final Trade: Tempus AI

Bill Baruch went with Tempus AI as his final trade. He described it as a small healthcare technology company with a great management team working to cure cancer, and he added it to portfolios as a starter position last week. Watch the full discussion here.

Share

Latest Insights

Our team at Blue Line Capital, led by founder Bill Baruch, shares their expertise and unique market perspective.